Member Exclusive News

Alzheimer’s disease prevented by pharmacological chaperone therapy in mice

Pharmacological chaperones have proved successful in mediating the activity of VPS35 in mice models of Alzheimer’s disease – resulting in a reduction of tau and amyloid beta aggregates when compared to untreated mice.

Go to the profile of Harriet Wall
Jan 22, 2020

Please sign in or register for FREE

No comments yet.